German Capital Markets Stock News

TeamViewer (XTRA:TMV) posted robust earnings, with net profit margins rising to 17.8% from 16.3% a year ago. Over the last five years, annual earnings have grown by 11.1%, while the most recent twelve months saw a 19.6% jump in earnings. With earnings forecast to grow by 14.1% per year and revenue expected to increase at 7.7% annually, outpacing the broader German market, investors have plenty of growth drivers to watch. At the same time, share price and financial stability risks remain part...

Key Insights Significantly high institutional ownership implies LANXESS' stock price is sensitive to their trading...

The simplest way to benefit from a rising market is to buy an index fund. Active investors aim to buy stocks that...

IONOS Group SE ( ETR:IOS ), might not be a large cap stock, but it saw significant share price movement during recent...

While Elmos Semiconductor SE ( ETR:ELG ) might not have the largest market cap around , it saw a decent share price...

Key Insights Significantly high institutional ownership implies Fresenius SE KGaA's stock price is sensitive to their...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Beiersdorf fair value estimate is €129 Current share price of...

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...

While ATOSS Software SE ( ETR:AOF ) might not have the largest market cap around , it received a lot of attention from...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

Most readers would already be aware that PVA TePla's (ETR:TPE) stock increased significantly by 41% over the past three...

On October 13, 2025, SQ Innovation received FDA approval for Lasix ONYU, a combination product featuring Gerresheimer’s proprietary on-body infusor for at-home subcutaneous drug delivery in select congestive heart failure patients. This milestone showcases Gerresheimer’s technological capabilities in advanced drug delivery devices and highlights its growing position as a full-service partner to pharmaceutical companies embracing home-based care. Next, we’ll explore how the FDA-backed rollout...

Sartorius Aktiengesellschaft has recently reported its third quarter and nine-month results for 2025, highlighted by increased sales to €843.2 million and a rise in net income to €43.8 million, also raising its full-year 2025 financial guidance after considering the MATTEK acquisition and market conditions. An interesting point is Sartorius' management specifically sharpened its guidance, factoring in strong year-to-date performance, new tariffs, acquisition impact, and comparisons to the...

The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...

It's easy to match the overall market return by buying an index fund. While individual stocks can be big winners...

If you're looking at a mature business that's past the growth phase, what are some of the underlying trends that pop...

Jenoptik AG ( ETR:JEN ) shareholders should be happy to see the share price up 18% in the last month. But that doesn't...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Most readers would already be aware that ad pepper media International's (ETR:APM) stock increased significantly by 20...

Ceconomy AG was recently removed from the Germany Small DAX (Total Return) Index, changing its status among tracked German equities. This exclusion may affect its visibility and demand from funds that track the index, influencing the company’s relationship with institutional investors. We’ll explore how Ceconomy's index removal may impact its investment case, especially regarding its profile among index-oriented investors. We've found 18 US stocks that are forecast to pay a dividend yield of...

Südzucker (XTRA:SZU) just posted its latest half-year results, showing a clear shift in momentum as both sales and profits declined compared to last year and moved into the red for the period. See our latest analysis for Südzucker. The sharp decline in Südzucker’s recent earnings, swinging from profit to loss, appears to have weighed on investor sentiment. After a brief uptick, the share price has slipped this year, with a 1-year total shareholder return of -8.9%, reflecting fading market...

Continental (XTRA:CON) released preliminary third-quarter numbers that landed above market expectations, with sales and adjusted EBIT margin both coming in ahead of estimates. The company’s Tires and ContiTech segments played a key role. See our latest analysis for Continental. Continental’s upbeat preliminary earnings have sparked a strong recovery in its share price, with an 11% rally in just one day and a 7% gain over the past week. While the stock had been under pressure through late...

Gerresheimer (XTRA:GXI) shares drew renewed attention after news that the US FDA approved the Lasix ONYU combination product, which features the company’s proprietary on-body drug delivery device. This regulatory win could prove commercially meaningful with 2025 launches approaching. See our latest analysis for Gerresheimer. Despite the lift from FDA approval of its new drug delivery device, Gerresheimer's share price has continued to face heavy pressure, with a 30-day share price return of...

Key Insights Given the large stake in the stock by institutions, SUSS MicroTec's stock price might be vulnerable to...